Monitoring for post-injection delirium/sedation syndrome with long-acting olanzapine during the COVID-19 pandemic

Aust N Z J Psychiatry. 2020 Jul;54(7):759-761. doi: 10.1177/0004867420927465. Epub 2020 May 14.

Dan Siskind^{1

2}, Korinne Northwood^{1

2}, Michael Berk^{3

4

5

6}, David Castle^{3

7}, Cherrie Galletly^{8

9}, Anthony Harris^{10

11}

¹ Princess Alexandra Hospital, Metro South Addiction and Mental Health Service, Woolloongabba, QLD, Australia.
² School of Clinical Medicine, The University of Queensland, Brisbane, QLD, Australia.
³ Department of Psychiatry, The University of Melbourne, Parkville, VIC, Australia.
⁴ IMPACT Strategic Research Centre, Barwon Health, Deakin University, Geelong, VIC, Australia.
⁵ Orygen Youth Health Research Centre, Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia.
⁶ The Florey Institute for Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.
⁷ Department of Psychiatry, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia.
⁸ Psychiatry Department, The University of Adelaide, Adelaide, SA, Australia.
⁹ Northern Adelaide Local Health Network, Adelaide, SA, Australia.
¹⁰ Discipline of Psychiatry, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.
¹¹ Brain Dynamics Centre, The Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia.

No abstract available

Publication types